Cellentia Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $50K

  • Investors
  • 1

Cellentia General Information

Description

Developer of next-generation patient-derived organoid testing services and translational bioassays designed to model real patient tumor biology. The company offers organoids generated from circulating tumor cells and primary tumors, together with cell-based potency and functional assays, enabling researchers and drug developers access to metastatic disease-relevant models that improve therapeutic decision-making and reduce development risk.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 319 North Bernardo Avenue
  • Mountain View, CA 94043
  • United States
+1 (650)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 319 North Bernardo Avenue
  • Mountain View, CA 94043
  • United States
+1 (650)

Cellentia Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellentia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 20-Jul-2025 $50K Completed Startup
4. Accelerator/Incubator 27-Sep-2024 Completed Generating Revenue
3. Angel (individual) 28-Feb-2024 Completed Startup
2. Angel (individual) 16-Jun-2023 $150K $250K Completed Startup
1. Capitalization 12-Jan-2023 $100K $100K Completed Startup
To view Cellentia’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellentia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellentia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
H7 BioCapital Venture Capital Minority
To view Cellentia’s complete investors history, request access »

Cellentia FAQs

  • When was Cellentia founded?

    Cellentia was founded in 2022.

  • Where is Cellentia headquartered?

    Cellentia is headquartered in Mountain View, CA.

  • What is the size of Cellentia?

    Cellentia has 4 total employees.

  • What industry is Cellentia in?

    Cellentia’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Cellentia a private or public company?

    Cellentia is a Private company.

  • What is Cellentia’s current revenue?

    The current revenue for Cellentia is .

  • How much funding has Cellentia raised over time?

    Cellentia has raised $580K.

  • Who are Cellentia’s investors?

    H7 BioCapital has invested in Cellentia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process